News

Filter

Current filters:

Boehringer Ingelheim

76 to 85 of 96906 results

Reckitt Benckiser outlines plans for demerger of the RB Pharma business

17-11-2014

Following the announcement made by UK-based consumer goods giant Reckitt Benckiser that it was pursuing…

FinancialIndiviorMergers & AcquisitionsPharmaceuticalReckitt BenckiserReckitt Benckiser Pharmaceuticals

Yet another indication for Roche’s blockbuster Avastin from FDA

16-11-2014

The US Food and Drug Administration on Friday approved Avastin (bevacizumab) solution for intravenous…

AvastinBiotechnologyEli LillyGemzarGenentechOncologyRegulationRocheUSA

Positive results from COMBI-v study of Mekinist and Tafinlar

16-11-2014

Results published in the New England Journal of Medicine show that treatment with the combination of…

GlaxoSmithKlineMekinistOncologyPharmaceuticalResearchTafinlar

FDA at last approves Genzyme’s Lemtrada

FDA at last approves Genzyme’s Lemtrada

15-11-2014

The US Food and Drug Administration on Friday approved French pharma major Sanofi subsidiary Genzyme’s…

BayerBiotechnologyGenzymeLemtradaNeurologicalRegulationSanofiUSA

International Diabetes Federation releases focus on Middle East

14-11-2014

The International Diabetes Federation has published its sixth Diabetes Atlas with a particular focus…

DiabetesMiddle EastPharmaceuticalResearchRest of the World

EU Tribunal annuls appointment of EMA Executive Director Rasi

EU Tribunal annuls appointment of EMA Executive Director Rasi

14-11-2014

The European Union Civil Service Tribunal yesterday gave its judgement on a case involving an appeal…

EMAEuropeLegalManagementPharmaceutical

Bristol-Myers plans biologics manufacturing facility in Ireland

14-11-2014

US pharma major Bristol-Myers Squibb plans to construct a new state-of-the-art, large-scale biologics…

BiotechnologyBristol-Myers SquibbIrelandProduction

ALK Abello reports positive financials for third quarter with sales up 3%

ALK Abello reports positive financials for third quarter with sales up 3%

14-11-2014

Denmark-based allergy specialist ALK Abello has reported positive results for the third quarter of 2014.

ALK AbelloDenmarkFinancialGrazaxPharmaceuticalRespiratory and Pulmonary

Study shows mutations in NPC1L1 protein cut coronary heart disease

Study shows mutations in NPC1L1 protein cut coronary heart disease

14-11-2014

A new study part-funded by US pharma giant Merck & Co (NYSE: MRK) has found that mutations in a gene…

Cardio-vascularCoronary heart diseaseMerck & CoPharmaceuticalResearchUnited StatesUSAZetia

76 to 85 of 96906 results

Back to top